{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33399484",
  "DateCompleted": {
    "Year": "2021",
    "Month": "03",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "03",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "14"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1080/07357907.2020.1871485"
    ],
    "Journal": {
      "ISSN": "1532-4192",
      "JournalIssue": {
        "Volume": "39",
        "Issue": "3",
        "PubDate": {
          "Year": "2021",
          "Month": "Mar"
        }
      },
      "Title": "Cancer investigation",
      "ISOAbbreviation": "Cancer Invest"
    },
    "ArticleTitle": "Risk and Benefit of Antiplatelet Therapy in COVID-19 Patients with Cancer and Thrombocytopenia: Letter to the Editor.",
    "Pagination": {
      "StartPage": "217",
      "EndPage": "218",
      "MedlinePgn": "217-218"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, School of Medicine, Shahid Mostafa Khomaeini Hospital, Ilam University of Medical sciences, Ilam, Iran."
          }
        ],
        "LastName": "Nourmohammadi",
        "ForeName": "Hassan",
        "Initials": "H"
      },
      {
        "Identifier": [
          "0000-0003-2588-3957"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Research Development Unit, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran."
          }
        ],
        "LastName": "Azami",
        "ForeName": "Golnaz",
        "Initials": "G"
      },
      {
        "Identifier": [
          "0000-0002-2566-5135"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Research Development Unit, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran."
          }
        ],
        "LastName": "Taghinezhad",
        "ForeName": "Fakhredin",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Research Development Unit, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran."
          }
        ],
        "LastName": "Shafiei",
        "ForeName": "Elham",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Cancer Invest",
    "NlmUniqueID": "8307154",
    "ISSNLinking": "0735-7907"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Platelet Aggregation Inhibitors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Platelet Aggregation Inhibitors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Thrombocytopenia"
    }
  ]
}